Virtual and Physical Health Assessments and Treatment Plans

Overview

The aim of the current study is to compare virtual clinic visits (i.e., real-time, face-to-face visits conducted over the internet with tablet devices) to actual physical clinic visits. After both types of visits (virtual versus physical) physicians will be asked to classify patients into low, moderate or high risk for a vascular intervention. It is hypothesized that there will be good agreement between classifications made after the virtual visits as compared to those made after physical visits. That is, virtual visit classifications will be as good as those made after physical visits.

Full Title of Study: “Comparison of Virtual to Physical Health Assessments and Treatment Plans for Patients Presenting for Initial Vascular Clinic Visits”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2022

Detailed Description

Patient dissatisfaction can increase because of the complexities associated with navigating modern health care systems. It is easy to speculate that some of this dissatisfaction is associated with travel, wait times and other issues that arise during routine clinic visits. The authors of recent studies have demonstrated that it is possible and feasible to conduct many routine visits remotely. It is our belief that virtual health assessments and treatment plans (VHAT) conducted remotely can be as effective, perhaps be more efficient and increase patient satisfaction when compared to regular physical health assessments and treatment plans (PHAT). Physicians want to provide optimal health care; however, in geographically isolated areas such as some locations in West Virginia that can be a challenge. It seems reasonable to believe that monitoring patients with telehealth technology, collecting on-going real time data and conducting VHAT can provide high quality health care for patients. It can also help to classify health risk, increase patient and medical staff satisfaction, decrease staff time for visits, while at the same time increase the efficiency of the follow-up process. The investigators plan to compare the physician assessments and future treatment plans made using VHAT to those made after PHAT. It is believed that VHAT assessments will be in agreement with those made with PHAT.

Interventions

  • Procedure: Virtual visit
    • Type of visit

Arms, Groups and Cohorts

  • Experimental: Type of visit
    • Single arm, non-randomized crossover design. All patients will receive both types of visits virtual and physical, and after assessments are made, participants will be classified by physicians into low, moderate or high risk for intervention.

Clinical Trial Outcome Measures

Primary Measures

  • Categorization of physician treatment plans. (Physicians will classify treatment plans as low, moderate or high need for vascular intervention)
    • Time Frame: 1 week
    • Comparison of virtual visit treatment plans to physical treatment plans. After assessments, physicians will classify patients’ treatment plans into low (treat medically), moderate (vascular intervention in the future, but not immediately) or high (needs immediately, within 2 weeks). The distribution of low, moderate and high among the two types of visits (Virtual and Physical) will be compared.

Secondary Measures

  • Patient satisfaction
    • Time Frame: 1 week
    • Comparison of patient satisfaction after virtual and physical visits. Satisfaction will be measured by two survey questions based on a 1 to 5 Likert scale.

Participating in This Clinical Trial

Inclusion Criteria

-Patients referred to and scheduled for an initial visit at our Vascular Center of Excellence (VCOE). Exclusion Criteria:

  • Patients that are deemed urgent cases by the VCOE, and scheduled within two weeks for the initial clinic visit. – Patients who are scheduled to have the placement of an arteriovenous (AV) fistula at the time of the initial clinic visit.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • CAMC Health System
  • Collaborator
    • Sarah & Pauline Maier Foundation, Inc.
  • Provider of Information About this Clinical Study
    • Principal Investigator: Albeir Mousa, Principal Investigator – CAMC Health System
  • Overall Contact(s)
    • Albeir Y Mousa, MD, 3043884875, amousa@hsc.wvu.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.